U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (MEDI5083)Cat. No. WA1708Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (MEDI5083)Cat. No. WA1708
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (LVGN7409)Cat. No. WA1707
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (KPL-404)Cat. No. WA1706
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (FFP 104)Cat. No. WA1705
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (CDX 1140)Cat. No. WA1704
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (BMS-986325)Cat. No. WA1703
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (BMS-986090)Cat. No. WA1702
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (BI 655064)Cat. No. WA1701
U-Blot® Research Grade Anti-Human CD40/TNFRSF5 (2141-V11)Cat. No. WA1700
U-Blot® Research Grade Anti-Human CD4 (TRX1)Cat. No. WA1699
U-Blot® Research Grade Anti-Human CD4 (M-T413)Cat. No. WA1698
U-Blot® Research Grade Anti-Human CD4 (IT1208)Cat. No. WA1697